Fanconi Anemia: Guidelines for Diagnosis and Management

Fanconi Anemia: Guidelines for Diagnosis and Management, published in 2008, replaces the second edition, Standards for Clinical Care; it is available as a hard copy and here, electronically.

To receive a hard copy, please e-mail your request and contact details to info@fanconi.org, or call us toll free at 1-888-FANCONI (1-888-326-2664) within the United States, or at 541-687-4658 outside the US.

To view this electronic version in pdf format, Adobe Reader is required. (Download a free copy of Adobe Reader).

Fanconi Anemia: Guidelines for Diagnosis and Management (2008) (full book)

View chapters and components separately below:

Cover
Front Matter
Table of Contents
Introduction
Chapter 1: Clinical Management Checklist
Chapter 2: Diagnostic Evaluation of FA
Chapter 3: Treatment of Hematologic Abnormalities in FA
Chapter 4: Gastrointestinal, Hepatic, and Nutritional Problems in FA
Chapter 5: Hand and Arm Differences in FA
Chapter 6: Gynecologic and Fertility Issues in Female FA Patients
Chapter 7: Endocrine Disorders in FA
Chapter 8: Hearing and Ear Abnormalities in Fanconi Anemia
Chapter 9: Matched Sibling Donor Hematopoietic Stem Cell Transplantation
Chapter 10: Unrelated Donor Hematopoietic Stem Cell Transplantation
Chapter 11: Late Effects in Fanconi Anemia Patients Post-Transplant
Chapter 12: Novel Treatment Options
Chapter 13: Head and Neck Squamous Cell Carcinoma in FA Patients
Chapter 14: The Adult FA Patient
Chapter 15: Genetic Counseling
Chapter 16: Psychosocial Issues
Chapter 17: Mother's Perspective: The Grieving Process and the Physician's Role
Appendix: Participants and Contributors
Glossary
Index

The Spanish translation of this handbook is forthcoming. View the second edition in Spanish below:

Anemia de Fanconi: Normas para los cuidados clínicos (2003)

The guidelines for diagnosis and management of Fanconi anemia were developed at a consensus conference sponsored by the Fanconi Anemia Research Fund in April 2008. The Fund owes a tremendous debt of gratitude to Eva Guinan, MD, Dana-Farber Cancer Institute, for serving as moderator of the conference and to all the participants for donating their time and expertise to develop these standards. Special thanks to Mary Ellen Eiler and Joyce Owen, PhD, Eugene, OR, for editing the book.

The participants in the consensus conference from which the guidelines were derived include the following:

• Blanche Alter, MD, MPH, National Cancer Institute
• K. Scott Baker, MD, MS, University of Minnesota Medical School
• Marc Bierings, MD, PhD, University Children's Hospital Utrecht
• Farid Boulad, MD, Memorial Sloan-Kettering Cancer Center
• Thomas Carroll, FRCS, Royal Hallamshire Hospital
• Andrew Eichenfield, MD, Medical Director, Camp Sunshine, Sebago Lake, Maine
• Rahel Ghebre, MD, University of Minnesota
• Alfred Gillio, MD, Hackensack University Medical Center
• Eva C. Guinan, MD, Dana-Farber Cancer Institute
• Jill Huppert, MD, MPH, Cinncinnati Children's Hospital Medical Center
• H. Jeffrey Kim, MD, National Institute on Deafness and Other Communication Disorders, NIH
• Jeffrey M. Lipton, MD, PhD, Schneider Children's Hospital, New Hyde Park, NY
• Margaret MacMillan, MD, University of Minnesota Medical School
• Zora R. Rogers, MD, University of Texas Southwestern Medical Center
• Susan Rose, MD, Cincinnati Children's Hospital Medical Center
• Sarah Jane Schwarzenberg, MD, University of Minnesota Medical School
• Akiko Shimamura, MD, PhD, Dana-Farber Cancer Institute
• Pamela Stratton, MD, National Institute of Child Health and Human Development, NIH
• Holger Toennies, PhD, University of Kiel
• Jakub Tolar, MD, PhD, University of Minnesota Medical School
• Eunike Velleuer, MD, Children's Hospital, Dusseldorf
• John E. Wagner, MD, Univeristy of Minnesota Medical School
• Christopher Walsh, MD, PhD, Mount Sinai School of Medicine
• Nada Yazigi, MD, Cincinnati Children's Hospital Medical Center